John W. Babich,Craig Zimmerman,John L. Joyal,Genliang Lu
申请号：
US14152864
公开号：
US09447121B2
申请日:
2014.01.10
申请国别(地区):
US
年份:
2016
代理人:
摘要：
Compounds according to Formula I and Formula II are potent inhibitors of PSMA.Pharmaceutical compositions may include a complex of a radionuclide and a Formula I compound or a Formula II compound. Methods include using the radionuclide complex of a Formula I compound or a Formula II compound for treating or diagnosis of a disease or a condition associated with PSMA activity.
